Comparable kidney transplant outcomes in selected patients with a body mass index ≥ 40: A personalized medicine approach to recipient selection
Clinical Transplantation · 2023-08 · 37 (8)
DOI: 10.1111/ctr.14903 ↗At a glance
Journal article in Clinical Transplantation, published online on 2023-03-31. Written by Marie L Jacobs and 8 co-authors. Institution: University of Rochester School of Medicine, Rochester, New York, USA. Major MEDLINE topics: Kidney Transplantation. Cited 6 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Introduction
Many kidney transplant (KT) centers decline patients with a body mass index (BMI) ≥40 kg/m 2 . This study's aim was to evaluate KT outcomes according to recipient BMI.
Methods
We performed a single‐center, retrospective review of adult KTs comparing BMI ≥40 patients ( n = 84, BMI = 42 ± 2 kg/m 2 ) to a matched BMI < 40 cohort ( n = 84, BMI = 28 ± 5 kg/m 2 ). Patients were matched for age, gender, race, diabetes, and donor type.
Results
BMI ≥40 patients were on dialysis longer (5.2 ± 3.2 years vs. 4.1 ± 3.5 years, p = .03) and received lower kidney donor profile index (KDPI) kidneys (40 ± 25% vs. 53 ± 26%, p = .003). There were no significant differences in prevalence of delayed graft function, reoperations, readmissions, wound complications, patient survival, or renal function at 1 year. Long‐term graft survival was higher for BMI ≥40 patients, including after adjusting for KDPI (BMI ≥40: aHR = 1.79, 95% CI = 1.09–2.9). BMI ≥40 patients had similar BMI change in the first year post‐transplant (delta BMI: BMI ≥ 40 +.9 ± 3.3 vs. BMI < 40 +1.1 ± 3.2, p = .59).
Conclusions
Overall outcomes after KT were comparable in BMI ≥40 patients compared to a matched cohort with lower BMI with improved long‐term graft survival in obese patients. BMI‐based exclusion criteria for KT should be reexamined in favor of a more individualized approach.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- University of Rochester School of Medicine, Rochester, New York, USA.
- University of Washington Medical Center, Seattle, Washington, USA.
- Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
- Department of Surgery, Section of Transplantation, Atrium Health Wake Forest Baptist, Winston Salem, North Carolina, USA.
- Department of Internal Medicine, Section of Nephrology, Atrium Health Wake Forest Baptist, Winston Salem, North Carolina, USA.
ORCID profiles: David I Harriman, Robert J Stratta, Giuseppe Orlando, Colleen Jay
Cite
APA
Jacobs, M. L., Dhaliwal, K., Harriman, D. I., Rogers, J., Stratta, R. J., Farney, A. C., Orlando, G., Reeves-Daniel, A., & Jay, C. (2023). Comparable kidney transplant outcomes in selected patients with a body mass index ≥ 40: A personalized medicine approach to recipient selection. Clinical Transplantation, 37(8). https://doi.org/10.1111/ctr.14903
Vancouver
Jacobs ML, Dhaliwal K, Harriman DI, Rogers J, Stratta RJ, Farney AC, et al. Comparable kidney transplant outcomes in selected patients with a body mass index ≥ 40: A personalized medicine approach to recipient selection. Clinical Transplantation. 2023;37(8). doi:10.1111/ctr.14903
BibTeX
@article{Jacobs2023,
author = {Jacobs, Marie L and Dhaliwal, Karanpreet and Harriman, David I and Rogers, Jeffrey and Stratta, Robert J and Farney, Alan C and Orlando, Giuseppe and Reeves-Daniel, Amber and Jay, Colleen},
title = {Comparable kidney transplant outcomes in selected patients with a body mass index ≥ 40: A personalized medicine approach to recipient selection},
journal = {Clinical Transplantation},
year = {2023},
volume = {37},
number = {8},
doi = {10.1111/ctr.14903}
}
EUVIMED